Clinical Trial Update: A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating different doses of BI 765049 in adults with advanced colorectal cancer, gastric cancer, or pancreatic ductal adenocarcinoma; recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• BI 765049 (BI-765049)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Colorectal Carcinoma, Gastric Carcinoma | Phase 1 | Status: RECRUITING